TIPE2/NF-kappaB signaling axis in osteosarcoma: mechanistic insights into its role in tumor progression

Authors: Banik, Kishore; Bordoloi, Devivasha; Hegde, Mangala; Harsha, Choudhary; Padmavathi, Ganesan; Kunnumakkara, Ajaikumar B

Source journal: Naunyn-Schmiedeberg's archives of pharmacology (2026-11-19)

DOI: 10.1007/s00210-026-06016-y

Abstract

In this study, we examined the expression and cell-intrinsic function of TIPE2 in human osteosarcoma (OS). Notably, increased levels of TIPE2 expression have been observed in OS cell lines and tissues compared to normal cells and tissues, respectively. Furthermore, inhibition of TIPE2 expression through siRNA resulted in a marked reduction in the proliferative capacity, viability, and invasive characteristics of OS cells. This attenuation in OS cellular behavior was concomitant with observed alterations in autophagy-associated markers. In addition, the suppression of TIPE2 expression downregulated the expression of survivin, COX-2, cyclin A2, cyclin E, CDK-2, Runx2, MMP-9, N-cadherin, and Twist 1, while concurrently upregulated LC3B, E-cadherin, p62, p53, p21 and caspase-3. These alterations appear to be fundamentally associated with the NF-kappaB signaling cascade. Furthermore, our investigations revealed that the silencing of TIPE2 did not elicit significant changes in the expression levels of TNF-alpha, TNF-beta, or TNFR1. However, it inhibited RANKL expression and NF-kappaB activation. Additionally, we demonstrated that silencing NF-kappaB does not influence TIPE2 expression, but the silencing of TNF-alpha and TNFR1 effectively inhibits TIPE2 expression. These observations suggest that TIPE2 operates downstream of TNF-alpha and TNFR1 but upstream of NF-kappaB. In summary, our findings identify TIPE2 as a candidate mediator of OS pathogenesis, and indicate that TIPE2 warrants further validation in vivo and in patient cohorts to establish it as a promising avenue for therapeutic intervention in OS.

Read the full text

Related topics

Related open access articles

Abstract and bibliographic data from PubMed (U.S. National Library of Medicine). Copyright of the abstract belongs to the original publisher or authors.